CompletedNot applicableNCT03531216

Topical Rosemary Oil Application in Systemic Sclerosis

Studying Diffuse cutaneous systemic sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
ARCIM Institute Academic Research in Complementary and Integrative Medicine
Principal Investigator
Jan Vagedes, Dr.
ARCIM Institute; University of Tuebingen
Intervention
Rosemary essential oil(other)
Enrollment
12 enrolled
Eligibility
18 years · All sexes
Timeline
20152016

Study locations (2)

Collaborators

University Hospital Tuebingen

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03531216 on ClinicalTrials.gov

Other trials for Diffuse cutaneous systemic sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Diffuse cutaneous systemic sclerosis

← Back to all trials